IMNN is trading 5.5% down at $2.17 with no fresh company-specific news or filings to explain the move.

  • The drop appears related to typical volatility in a thinly traded biotech stock rather than a new fundamental development for Imunon.
  • The decline occurs against a backdrop of generally positive broader market indices.